Professor Stephanie McKeown: Awarded Weiss Medal 2013

OncoTherics Director, Professor Stephanie McKeown has been awarded the 2013 Weiss Medal!

Weiss Medallists are nominated by the Chairman of the Association for Radiation Research, after suitable consultations, as having made distinguished contributions to radiation science.

Professor "Joe" Weiss's research projects with Haber in the 1930's are widely-known as landmarks in chemical science. For over twenty-five years he published many distinguished papers in radiation chemistry and was the first radiation chemist to attempt to unravel systematically the complex interaction between biologically important molecules and free radicals produced upon the radiolysis of water. Many of his students and collaborators have since continued this pioneering work and have made distinguished contributions to radiation chemistry and molecular radiobiology themselves.

Professor Stephanie McKeown is the latest recipient of the prestigious Weiss medal. You can read more about the award at the Association for Radiation Research webpages.

Chancellor George Osborne visits OncoTherics Exhibition

The Chancellor George Osborne paid a visit to the OncoTherics exhibition stand at the Conservative conference Start-up hub this week.

The Chancellor was able to hear about OncoTherics' exciting new drug technology OCT1002 and the company's recent tenancy at the BioHub at Alderley Park, Alderley Edge, Cheshire.

The picture above shows the Chancellor and Stefan Ogrodzinski, Director OncoTherics, explaining the importance of hypoxia in cancer relapse and cancer spread.

Read more about the story on the Chancellors website: CLICK HERE

OncoTherics presentation to the 2013 Conservative Party Conference Start-up Hub Competition

As part of the Start-up hub competition at the 2013 Conservative Party conference, competing start-up companies were asked to make a short "elevator pitch" that would be transmitted to the conference audience each day by video.

The video below is the OncoTherics pitch. Enjoy! 

OncoTherics voted BEST START-UP COMPANY at the Conservative Party Conference 2013

OncoTherics has won the title “Best Start-Up Company” at the 2013 Conservative Party Conference. The company was voted the winner by hundreds of delegates at the conference in Manchester.

Delegates were invited to visit the “Start-Up Hub” area of the exhibition hall to meet the founders of twelve new companies from across the UK, before being invited to choose a winner by placing a ball in the corresponding tube of the most impressive company.   

Representatives from OncoTherics also had the opportunity to explain the company's technology and opportunity to the Prime Minister and the Chancellor, before being presented with a certificate by the competition organiser Damien Collins MP. OncoTherics also received a tablet computer awarded by competition sponsors, Fujitsu.

OncoTherics has developed a patented drug, which targets the most aggressive cancer cells in tumours by honing in on the hypoxic (low oxygen) characteristics of these cells. The company is currently looking for investors to fund the drug’s development to get it from the laboratory into the hands of clinicians, where it could potentially improve the lives of thousands of cancer patients every year, particularly those with aggressive Pancreatic cancer or Prostate cancer.

The company’s success also highlights that pharmaceutical drug discovery is alive and well in Great Britain, despite the tough economic climate and strong competition on the global pharmaceutical stage.    

Stefan Ogrodzinski, Director of OncoTherics commented:

“This win is a huge boost to the OncoTherics team. Showcasing our company at the Conservative Party Conference gave us a fantastic opportunity to raise awareness of the company, our exciting new drug technology and the investment opportunity. Our win shows the British public are as passionate about beating the most aggressive cancers as we are.”